Literature DB >> 1454817

Human fusion proteins between interleukin 2 and IgM heavy chain are cytotoxic for cells expressing the interleukin 2 receptor.

H Vié1, T Gauthier, R Breathnach, M Bonneville, A Godard, J Dietrich, G Karam, M C Gesnel, M A Peyrat, Y Jacques, J P Soulillou.   

Abstract

We have constructed a hybrid cDNA coding for a fusion protein between human interleukin 2 and a truncated heavy chain from human immunoglobulin M. The protein encoded by this cDNA contains the entire interleukin 2 sequence including its signal peptide, fused at its C terminus to domains 2 to 4 of the immunoglobulin heavy-chain constant region. Cells transfected with the hybrid cDNA secrete multimeric forms of the fusion protein, which bind specifically to cells bearing high-affinity interleukin 2 receptors. This binding leads either to T-cell proliferation or, if complement is added, to T-cell death. Multimeric forms of the fusion protein with a molecular mass above 500 kDa mediate complement-dependent lysis but trigger proliferation inefficiently when compared with forms with a low molecular mass (< 500 kDa). In contrast, the latter efficiently mediate T-cell proliferation without inducing complement-dependent lysis. The high molecular mass fusion proteins could thus constitute valuable tools for specific immunosuppression in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454817      PMCID: PMC50545          DOI: 10.1073/pnas.89.23.11337

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein.

Authors:  R L Kirkman; P Bacha; L V Barrett; S Forte; J R Murphy; T B Strom
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

2.  Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.

Authors:  A Traunecker; J Schneider; H Kiefer; K Karjalainen
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Designing CD4 immunoadhesins for AIDS therapy.

Authors:  D J Capon; S M Chamow; J Mordenti; S A Marsters; T Gregory; H Mitsuya; R A Byrn; C Lucas; F M Wurm; J E Groopman
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

4.  Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.

Authors:  A Kumar; J L Moreau; M Gibert; J Thèze
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

5.  The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.

Authors:  L M Matrisian; G T Bowden; P Krieg; G Fürstenberger; J P Briand; P Leroy; R Breathnach
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

6.  Effect of cyclosporine on interleukin 2 receptor expression in a human alloreactive T cell clone.

Authors:  D Chabannes; B Le Mauff; M M Hallet; Y Yacques; J P Soulillou
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

7.  Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2.

Authors:  Y Jacques; B Le Mauff; A Godard; D Olive; J F Moreau; J P Soulillou
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

8.  Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities.

Authors:  J F Moreau; M Bonneville; A Godard; H Gascan; V Gruart; M A Moore; J P Soulillou
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

9.  Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.

Authors:  H Lorberboum-Galski; D FitzGerald; V Chaudhary; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.

Authors:  R J Robb; W C Greene
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

View more
  3 in total

1.  Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.

Authors:  U Kunzendorf; T Pohl; S Bulfone-Paus; H Krause; M Notter; A Onu; G Walz; T Diamantstein
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

2.  Detection of weak receptor-ligand interactions using IgM and J-chain-based fusion proteins.

Authors:  Johannes U Ammann; Martin Jahnke; Michael R Dyson; Jim Kaufman; John Trowsdale
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

3.  Cooperativity to increase Turing pattern space for synthetic biology.

Authors:  Luis Diambra; Vivek Raj Senthivel; Diego Barcena Menendez; Mark Isalan
Journal:  ACS Synth Biol       Date:  2014-08-22       Impact factor: 5.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.